Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 10:9:672131.
doi: 10.3389/fped.2021.672131. eCollection 2021.

Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates

Affiliations

Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates

Roberta Vitali et al. Front Pediatr. .

Abstract

Introduction: An early diagnosis of necrotizing enterocolitis (NEC), a major gastrointestinal emergency in preterm newborns, is crucial to improve diagnostic approach and prognosis. We evaluated whether fecal high-mobility group box protein 1 (HMGB1) may early identify preterms at risk of developing NEC. Materials and Methods: A case-control study including neonates admitted at the Neonatal Intensive Care Unit (NICU) of the Sapienza University Hospital "Umberto I" in Rome, from July 2015 to December 2016. Stool samples obtained from cases (preterm newborns with NEC) and controls (newborns without NEC) were collected at the enrolment (T0) and within 7-14 days after the first sample collection (T1). HMGB1, extracted and measured with western blot, was reported as densitometry units (DUS). Results: HMGB1 levels in 30 cases (n = 28-Bell stage 1, n = 2 Bell stage 2) were higher [T0: 21,462 DUS (95% CI, 16,370-26,553 DUS)-T1: 17,533 DUS (95% CI, 13,052-22,014 DUS)] than in 30 preterm controls [T0: 9,446 DUS (95% CI, 6,147-12,746 DUS)-T1: 9,261 DUS (95% CI, 5,126-13,396 DUS), p < 0.001). Preterm newborns showed significant higher levels of HMGB1 (15,690 DUS (95% CI, 11,929-19,451 DUS)] in comparison with 30 full-term neonates with birth weight >2,500 g [6,599 DUS (95% CI, 3,141-10,058 DUS), p = 0.003]. Multivariate analysis showed that the risk of NEC was significantly (p = 0.012) related to the HMGB1 fecal levels at T0. Conclusions: We suggest fecal HMGB1 as a reliable marker of early NEC in preterm neonates. This study supports further investigation on the role of fecal HMGB1 assessment in managing preterm newborns at risk of NEC. Further studies are advocated to evaluate diagnostic accuracy of this marker in more severe forms of the disease.

Keywords: HMGB1; feeding intolerance; necrotizing enterocolitis; newborns; preterm.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
High-mobility group box 1 (HMGB1) fecal levels. The spacing between different parts of the box indicates interquartile range. Horizontal bold black line indicates median. The whiskers above and below the box show the locations of the minimum and the maximum. HMGB1, high-mobility group box 1; DUS, densitometry units; NEC, necrotizing enterocolitis.
Figure 2
Figure 2
High-mobility group box 1 fecal (HMGB1) levels according to days of postnatal life. The spacing between different parts of the box indicates interquartile range. Horizontal bold black line indicates median. The whiskers above and below the box show the locations of the minimum and the maximum. HMGB1, high-mobility group box 1; DUS, densitometry units; NEC, necrotizing enterocolitis.

Similar articles

Cited by

References

    1. Ou J, Courtney CM, Steinberger AE, Tecos ME, Warner BW. Nutrition in necrotizing enterocolitis and following intestinal resection. Nutrients. (2020) 12:520. 10.3390/nu12020520 - DOI - PMC - PubMed
    1. Joosten K, Embleton N, Yan W, Senterre T, Braegger C, Bronsky J, et al. . ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: energy. Clin Nutr. (2018) 37:2309–14. 10.1016/j.clnu.2018.06.944 - DOI - PubMed
    1. Hartman C, Shamir R, Simchowitz V, Lohner S, Cai W, Decsi T, et al. . ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: complications. Clin Nutr. (2018) 37:2418–29. 10.1016/j.clnu.2018.06.956 - DOI - PubMed
    1. Kumar RK, Singhal A, Vaidya U, Banerjee S, Anwar F, Rao S. Optimizing nutrition in preterm low birth weight infants—consensus summary. Front Nutr. (2017) 4:20. 10.3389/fnut.2017.00020 - DOI - PMC - PubMed
    1. Battersby C, Longford N, Mandalia S, Costeloe K, Modi N. Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012–13: a whole-population surveillance study. Lancet Gastroenterol Hepatol. (2017) 2:43–51. 10.1016/S2468-1253(16)30117-0 - DOI - PubMed